News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
246,281 Results
Type
Article (7951)
Company Profile (20)
Press Release (238310)
Section
Business (69390)
Career Advice (336)
Deals (15665)
Drug Delivery (28)
Drug Development (37244)
Employer Resources (26)
FDA (6613)
Job Trends (5585)
News (129888)
Policy (12132)
Tag
Academia (677)
Alliances (17000)
Alzheimer's disease (574)
Approvals (6620)
Artificial intelligence (74)
Bankruptcy (151)
Best Places to Work (5130)
Breast cancer (85)
Cancer (806)
Cardiovascular disease (54)
Career advice (295)
CAR-T (64)
Cell therapy (163)
Clinical research (30945)
Collaboration (236)
Compensation (56)
COVID-19 (755)
C-suite (49)
Data (918)
Diabetes (77)
Diagnostics (2287)
Earnings (33243)
Events (32420)
Executive appointments (178)
FDA (7037)
Funding (200)
Gene therapy (98)
GLP-1 (152)
Government (1330)
Healthcare (6744)
Infectious disease (799)
Inflammatory bowel disease (53)
Interviews (46)
IPO (8202)
Job creations (709)
Job search strategy (255)
Layoffs (50)
Legal (2210)
Lung cancer (117)
Lymphoma (55)
Manufacturing (74)
Medical device (4842)
Medtech (4844)
Mergers & acquisitions (7665)
Metabolic disorders (194)
Neuroscience (710)
NextGen: Class of 2025 (1851)
Non-profit (855)
Northern California (924)
Obesity (105)
Opinion (70)
Patents (72)
People (16770)
Phase I (9850)
Phase II (13600)
Phase III (10241)
Pipeline (405)
Postmarket research (813)
Preclinical (3599)
Radiopharmaceuticals (116)
Rare diseases (128)
Real estate (1247)
Regulatory (9252)
Research institute (609)
Southern California (808)
Startups (944)
United States (7826)
Vaccines (132)
Weight loss (60)
Date
Last 7 days (340)
Last 30 days (934)
Last 365 days (17241)
2025 (735)
2024 (17470)
2023 (19820)
2022 (24325)
2021 (26807)
2020 (24739)
2019 (16910)
2018 (12142)
2017 (12290)
2016 (10417)
2015 (12691)
2014 (8850)
2013 (6549)
2012 (6744)
2011 (7503)
2010 (6788)
Location
Africa (195)
Arizona (46)
Asia (18508)
Australia (4878)
California (2061)
Canada (874)
China (191)
Colorado (84)
Connecticut (123)
Europe (30437)
Florida (283)
Georgia (47)
Illinois (152)
Indiana (97)
Japan (60)
Maryland (256)
Massachusetts (1532)
Michigan (47)
Minnesota (89)
New Jersey (715)
New York (656)
North Carolina (327)
Northern California (924)
Ohio (47)
Pennsylvania (507)
South America (334)
Southern California (808)
Texas (292)
Utah (51)
Virginia (50)
Washington State (290)
246,281 Results for "piramal enterprises limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Piramal Pharma Limited Announces Results for Q4 and FY2024
Piramal Pharma Limited, a leading global pharmaceuticals company, announced its standalone and consolidated results for the Fourth Quarter and Full Year ended 31st March 2024.
May 10, 2024
·
8 min read
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
Piramal Pharma Limited announced its standalone and consolidated results for the Third Quarter and Nine Months ended 31st December 2023.
January 30, 2024
·
7 min read
Press Releases
Piramal Pharma Limited Announces Consolidated Results for Q1FY25
July 26, 2024
·
6 min read
Press Releases
Piramal Pharma’s GHG Commitment Validated and Approved by SBTi
September 16, 2024
·
3 min read
Piramal Pharma Limited Announces Consolidated Results for Q1FY24
Piramal Pharma Limited, announced its consolidated results for the first quarter ended 30th June 2023.
August 3, 2023
·
6 min read
Piramal Pharma Solutions Commemorates Opening of Its ADC Manufacturing Expansion in Grangemouth, Scotland
Piramal Pharma Solutions, a Contract Development and Manufacturing Organization and part of Piramal Pharma Ltd., celebrated the opening of its expanded antibody-drug conjugate manufacturing facility in Grangemouth, Scotland, UK.
December 18, 2023
·
6 min read
Press Releases
Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work
July 30, 2024
·
4 min read
Press Releases
Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme, ‘Building Resilience for a Sustainable Tomorrow’
October 4, 2024
·
5 min read
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization, formally announced the launch of a world-class high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India.
October 17, 2023
·
4 min read
Business
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M) ended 31th December 2022.
February 8, 2023
·
8 min read
1 of 24,629
Next
